• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于四个与肝细胞癌卫星结节相关的基因,鉴定和验证一个预后模型。

Identification and validation of a prognostic model based on four genes related to satellite nodules in hepatocellular carcinoma.

机构信息

Department of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

The First Clinical Medical College of Jinan University, Guangzhou, China.

出版信息

Sci Rep. 2024 Jul 7;14(1):15633. doi: 10.1038/s41598-024-66610-z.

DOI:10.1038/s41598-024-66610-z
PMID:38972883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11228042/
Abstract

Satellite nodules is a key clinical characteristic which has prognostic value of hepatocellular carcinoma (HCC). Currently, there is no gene-level predictive model for Satellite nodules in liver cancer. For the 377 HCC cases collected from the dataset of Cancer Genome Atlas (TCGA), their original pathological data were analyzed to extract information regarding satellite nodules status as well as other relevant pathological data. Then, this study employed statistical modeling for prognostic model establishment in TCGA, and validation in International Cancer Genome Consortium (ICGC) cohorts and GSE76427. Through rigorous statistical analyses, 253 differential satellite nodules-related genes (SNRGs) were identified, and four key genes related to satellite nodules and prognosis were selected to construct a prognostic model. The high-risk group predicted by our model exhibited an unfavorable overall survival (OS) outlook and demonstrated an association with adverse worse clinical characteristics such as larger tumor size, higher alpha-fetoprotein, microvascular invasion and advanced stage. Moreover, the validation of the model's prognostic value in the ICGC and GSE76427 cohorts mirrored that of the TCGA cohort. Besides, the high-risk group also showed higher levels of resting Dendritic cells, M0 macrophages infiltration, alongside decreased levels of CD8 T cells and γδT cells infiltration. The prognostic model based on SNRGs can reliability predict the OS of HCC and is likely to have predictive value of immunotherapy for HCC.

摘要

卫星结节是肝癌(HCC)具有预后价值的关键临床特征。目前,肝癌的卫星结节尚无基因水平的预测模型。本研究对来自癌症基因组图谱(TCGA)数据集的 377 例 HCC 病例进行了分析,以提取卫星结节状态以及其他相关病理数据的信息。然后,本研究在 TCGA 中进行了预后模型建立的统计建模,并在国际癌症基因组联盟(ICGC)队列和 GSE76427 中进行了验证。通过严格的统计分析,鉴定出 253 个差异卫星结节相关基因(SNRGs),并选择与卫星结节和预后相关的四个关键基因构建预后模型。我们的模型预测的高危组表现出不利的总体生存(OS)前景,并与不良的临床特征相关,如肿瘤较大、甲胎蛋白水平较高、微血管侵犯和晚期。此外,该模型在 ICGC 和 GSE76427 队列中的验证与 TCGA 队列一致。此外,高危组还显示静止树突状细胞、M0 巨噬细胞浸润水平较高,CD8 T 细胞和γδT 细胞浸润水平较低。基于 SNRGs 的预后模型可以可靠地预测 HCC 的 OS,并且可能对 HCC 的免疫治疗具有预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/e7399393a506/41598_2024_66610_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/82427dc86230/41598_2024_66610_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/f934917898a7/41598_2024_66610_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/0657a0c9b9e7/41598_2024_66610_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/edc09d76bf17/41598_2024_66610_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/55b254159d76/41598_2024_66610_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/e7399393a506/41598_2024_66610_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/82427dc86230/41598_2024_66610_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/f934917898a7/41598_2024_66610_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/0657a0c9b9e7/41598_2024_66610_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/edc09d76bf17/41598_2024_66610_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/55b254159d76/41598_2024_66610_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a17/11228042/e7399393a506/41598_2024_66610_Fig6_HTML.jpg

相似文献

1
Identification and validation of a prognostic model based on four genes related to satellite nodules in hepatocellular carcinoma.基于四个与肝细胞癌卫星结节相关的基因,鉴定和验证一个预后模型。
Sci Rep. 2024 Jul 7;14(1):15633. doi: 10.1038/s41598-024-66610-z.
2
Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma.鉴定和验证与巨噬细胞和 CD8 T 细胞浸润相关的新型免疫相关特征,预测肝细胞癌的总生存期。
BMC Med Genomics. 2021 Sep 20;14(1):232. doi: 10.1186/s12920-021-01081-z.
3
A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma.基于基因的风险评分模型预测肝细胞癌患者无复发生存率。
BMC Cancer. 2021 Jan 5;21(1):6. doi: 10.1186/s12885-020-07692-6.
4
A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.铜死亡相关长链非编码 RNA 风险模型预测肝细胞癌患者的预后和免疫治疗疗效。
Biochem Genet. 2024 Jun;62(3):2332-2351. doi: 10.1007/s10528-023-10539-x. Epub 2023 Oct 29.
5
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.鉴定 Rad51 作为与肝癌免疫浸润相关的预后生物标志物。
Bioengineered. 2021 Dec;12(1):2664-2675. doi: 10.1080/21655979.2021.1938470.
6
Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.与肿瘤相关巨噬细胞相关的 8 基因代谢特征预测肝细胞癌的总生存期。
BMC Cancer. 2021 Jan 7;21(1):31. doi: 10.1186/s12885-020-07734-z.
7
Comprehensive evaluation of genes related to basement membrane in hepatocellular carcinoma.全面评估与肝细胞癌相关的基底膜基因。
Aging (Albany NY). 2024 Jun 12;16(11):10108-10131. doi: 10.18632/aging.205923.
8
Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.基于 TCGA 数据的肝癌肿瘤突变负荷和免疫浸润的预后分析。
Aging (Albany NY). 2021 Apr 4;13(8):11257-11280. doi: 10.18632/aging.202811.
9
Prognostic analysis and risk assessment based on RNA editing in hepatocellular carcinoma.基于 RNA 编辑的肝细胞癌预后分析与风险评估。
J Appl Genet. 2024 Sep;65(3):519-530. doi: 10.1007/s13353-023-00819-y. Epub 2024 Jan 13.
10
Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.鉴定和验证一种新型的六基因表达谱用于预测肝细胞癌预后。
Front Immunol. 2021 Dec 1;12:723271. doi: 10.3389/fimmu.2021.723271. eCollection 2021.

引用本文的文献

1
Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients.乙肝患者根治性切除术后肝细胞癌的机器学习预后模型
J Hepatocell Carcinoma. 2025 Feb 19;12:353-365. doi: 10.2147/JHC.S495059. eCollection 2025.

本文引用的文献

1
Targeting RORγ inhibits the growth and metastasis of hepatocellular carcinoma.靶向RORγ可抑制肝细胞癌的生长和转移。
Mol Ther. 2024 Mar 6;32(3):749-765. doi: 10.1016/j.ymthe.2024.01.032. Epub 2024 Feb 3.
2
Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinoma.程序性细胞死亡相关基因在肝细胞癌中的诊断作用及免疫相关性。
Sci Rep. 2023 Nov 22;13(1):20509. doi: 10.1038/s41598-023-47560-4.
3
Characteristics of gut microbiota in patients with metabolic associated fatty liver disease.
代谢相关脂肪性肝病患者的肠道微生物特征。
Sci Rep. 2023 Jun 20;13(1):9988. doi: 10.1038/s41598-023-37163-4.
4
Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging.肝细胞癌微血管侵犯的分类:与预后和磁共振成像的相关性。
Clin Mol Hepatol. 2023 Jul;29(3):733-746. doi: 10.3350/cmh.2023.0034. Epub 2023 May 8.
5
Epigenetics as a mediator of plasticity in cancer.表观遗传学作为癌症可塑性的介体。
Science. 2023 Feb 10;379(6632):eaaw3835. doi: 10.1126/science.aaw3835.
6
Global Epidemiology and Genetics of Hepatocellular Carcinoma.全球肝细胞癌的流行病学和遗传学
Gastroenterology. 2023 Apr;164(5):766-782. doi: 10.1053/j.gastro.2023.01.033. Epub 2023 Feb 2.
7
Mechanisms of drug resistance in HCC.肝癌耐药的机制。
Hepatology. 2024 Apr 1;79(4):926-940. doi: 10.1097/HEP.0000000000000237. Epub 2023 Jan 3.
8
Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.构建和验证与血管生成相关的评分模型,以预测肝细胞癌的预后、肿瘤免疫微环境和治疗反应。
Front Immunol. 2022 Nov 17;13:1013248. doi: 10.3389/fimmu.2022.1013248. eCollection 2022.
9
Exploration of a Novel Prognostic Nomogram and Diagnostic Biomarkers Based on the Activity Variations of Hallmark Gene Sets in Hepatocellular Carcinoma.基于肝细胞癌标志性基因集活性变化的新型预后列线图及诊断生物标志物探索
Front Oncol. 2022 Mar 10;12:830362. doi: 10.3389/fonc.2022.830362. eCollection 2022.
10
Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden.基于肿瘤突变负荷的肝细胞癌患者管理的诊断和预后模型。
J Adv Res. 2021 Feb 9;33:153-165. doi: 10.1016/j.jare.2021.01.018. eCollection 2021 Nov.